Restructuring and Impairment (Tables)

9 Months Ended

Sep. 30, 2026

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Reserve by Type of Cost

The Company’s restructuring expenses are comprised of the following (in millions):


	Three Months Ended September 30, 2026
	Cost of Revenues		Selling, general and administrative		Total
Severance and employee costs	$	0.2	$	0.6	$	0.8
Total	$	0.2	$	0.6	$	0.8


	Three Months Ended September 30, 2025
	Cost of Revenues		Selling, general and administrative		Total
Severance and employee costs	$	0.4	$	0.6	$	1.0
Total	$	0.4	$	0.6	$	1.0


	Nine Months Ended September 30, 2026
	Cost of Revenues		Selling, general and administrative		Total
Severance and employee costs	$	0.3	$	1.1	$	1.4
Total	$	0.3	$	1.1	$	1.4


	Nine Months Ended September 30, 2025
	Cost of Revenues		Selling, general and administrative		Total
Severance and employee costs	$	0.6	$	0.8	$	1.4
Total	$	0.6	$	0.8	$	1.4

Schedule of Restructuring and Related Costs

The following table summarizes restructuring expenses for each reportable segment (in millions):


	Three Months Ended September 30, 2026		Three Months Ended September 30, 2025		Nine Months Ended September 30, 2026		Nine Months Ended September 30, 2025

Restructuring expenses:
Nuclear & Safety	$	0.8	$	0.4	$	0.9	$	0.5
Medical	—		0.6		0.3		0.9
Corporate and other	—		—		0.2		—
Total	$	0.8	$	1.0	$	1.4	$	1.4

The following table summarizes the changes in the Company’s accrued restructuring balance for severance and employee costs, which are included in accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets (in millions):


Balance at December 31, 2025	$	0.3
Restructuring charges (excluding impairment)	1.4
Payments	(1.2)
Adjustments	—
Balance at September 30, 2026	$	0.5